Don Dion | TalkMarkets | Page 25
Chief Executive Officer of Inland Management
Contributor's Links: Inland Management DRD Investments
Don Dion is the CEO of Inland Management, a company focused on acquiring, subdividing, developing and marketing large tracts of land on the fringes of major metropolitan markets. Inland Management has sold land in ...more

All Contributions

Latest Posts
385 to 400 of 408 Posts
<<< 1 ... 23 24 25 26 >>>
Shop Till You Drop: New Research On IPOs, Ahead Of Shopify's Lockup Expiration
Our results from trading IPO lockup expirations have been extraordinary; as of August 2015, over 60% of the 208 related stocks we've shorted proved profitable in a short window of time.
Wave Life Sciences IPO: Hold Off
Wave Life Sciences Pte Ltd. expects to raise $80 million in its upcoming IPO.
Mesoblast IPO: A Chance To Take Off In The US
Mesoblast Inc. (NASDAQ: MESO) expects to raise close to $70 million in its upcoming IPO. Mesoblast filed for the IPO on November 2, 2015.
AIG Vs. Carl Icahn - Take Profits As Flux Continues
Recently, Carl Icahn's call on American International Group to break itself into three smaller companies has made headlines. Mr. Icahn believes that AIG, once considered to be too big to fail, is now too big to be successful.
IPO Lockup Expiration: Press Ganey Holdings
With fifteen individuals and funds currently possessing restricted PGND shares, the opportunity to short the stock is large. A new supply of shares available for public sale on November 17 could send PGND stock tumbling down.
Berkshire Hills Bancorp: An Excellent Small Financial Pick
For investors seeking a play in the financial industry, Berkshire Hills Bancorp (NYSE:BHLB) is an excellent, low-risk bet.
HP Drops Out Of The Race, Investors Should Drop Out Of HP
With confirmation that Hewlett-Packard's (NYSE:HPQ) attempt to move into the cloud arena is coming to an end, the outlook for the company continues to spiral.
MyoKardia IPO: Early Stage, Skittish IPO Market Leave Us Hesitant
MyoKardia Inc. expects to raise $73.6 million in its upcoming IPO. Based in South San Francisco, California, MyoKardia is a clinical-stage biopharmaceutical that is developing therapies for rare and serious cardiovascular diseases.
Unwrapping The Multi Packaging Solutions IPO
Multi Packaging Solutions Inc. expects to raise $300 million in its upcoming IPO. They will offer 18.75 million shares at an expected price range of $15 to $17.
Early Stage Status For Dimension Therapeutics Keeps Us Cautious On This IPO
Dimension Therapeutics expects to raise $82.5 million in its upcoming IPO. Based in Cambridge, Massachusetts, it is a biotechnology company with a gene therapy platform for developing treatments for rare diseases associated with the liver.
Ferrari Stomps On The Accelerator On Its IPO
New Business Netherlands NV (NYSE: RACE) (better known as Ferrari) expects to raise $858 million in its upcoming IPO.
General Electric: Nelson Peltz Takes A Position
As GE spins off its financial assets and focuses on its core industrials, growth is likely ahead for its investors. Some argue that industrials have been a weak spot in the US economy.
IPO Quiet Period Expiration - Penumbra
PEN's share prices will likely see a temporary rise in response to the release of the underwriter reports, opening another buying opportunity for this growing firm.
Time To Cash Out Of JPMorgan
As JPMorgan Chase readies itself to announce its 3rd quarter earnings on Oct. 13 at the close of trading, recent news for the company has been troubling.
Consider The CPI Card Group IPO
Despite the risk of a security breach, we are excited for this deal. CPI Card's work on mobile payments helps round out its business and a strong syndicate plus solid financial status is very encouraging.
Aclaris Therapeutics IPO: Consider Holding Off
Aclaris Therapeutics Inc. (ACRS) expects to raise $75 million in its upcoming IPO. ACRS filed for the IPO on August 17, 2015.
385 to 400 of 408 Posts
<<< 1 ... 23 24 25 26 >>>